ARCHIVES

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

January 29, 1982

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005

Eye Institute Director Kupfer Steps Down; UICC Begins Web-Based Surgical Pathology.

July 7, 2000

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored

November 18, 1994